Public Policy and Advocacy in Cancer Research: An Associate Member Guest Post

April symbolizes a progressive time for cancer researchers around the world. From April 1-5, over 20,000 cancer scientists will gather in Washington, D.C., to attend the American Association for Cancer Research (AACR) 2017 Annual Meeting.

Read More

Key Policy Sessions Set for AACR Annual Meeting 2017

In addition to the robust scientific program at this year’s AACR Annual Meeting in Washington, D.C., a number of sessions will provide a policy perspective on the meeting’s theme, “Research Propelling Cancer Prevention and Cures.”

Read More

AACR Speaks Out on Proposed Cuts to Medical Research Funding

The American Association for Cancer Research was shocked last week to learn that the Trump administration has proposed to cut $5.8 billion from the National Institutes of Health (NIH) budget in fiscal year 2018. We are working very hard to ensure that these proposed cuts to the NIH never happen.

Read More

New Therapeutic Approved by FDA to Treat Breast Cancer

Earlier this week, the U.S. Food and Drug Administration approved the molecularly targeted therapeutic ribociclib (Kisqali) for use in combination with any aromatase inhibitor for initial treatment of postmenopausal women with a hormone receptor (HR)–positive, HER2-negative, advanced breast cancer.

Read More